Biogen reported $7.86B in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Acorda Therapeutics ACOR:US $ 80.46M 21.7M
Amgen AMGN:US $ 18520M 865M
Bayer BAYN:GR 32.58B 633M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 45.72B 19.46B
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Teva Pharmaceutical TEVA:IT 12.57B 419M